
Market Update for Week of June 20, 2025
The Week at a Glance:
Markets Finish Flat: The three major US indices traded sideways during the week as investors digested continued geopolitical tensions between Israel and Iran, along with the Federal Reserve’s decision to not cut rates
Lilly’s Buying Spree: Just three weeks after Lilly paid $1.0B to acquire SiteOne Therapeutics, Eli Lilly has made headlines again through the acquisition of the gene editing and cardiovascular disease focused Verve Therapeutics for up to $1.3B
IPOs Continue to Favor Commercial Stage: Caris Life Sciences, a developer of AI-based genomics technology for diagnosis, raised an oversubscribed $494.1M IPO, marking the second largest healthcare IPO YTD and the 11th commercial IPO (out of 17 IPOs total)
